CTR-US for Carpal Tunnel Syndrome

Phase-Based Progress Estimates
Orthopedic Associates, Fort Walton Beach, FL
Carpal Tunnel Syndrome+2 More
CTR-US - Device
All Sexes
What conditions do you have?

Study Summary

Study to compare the safety and effectiveness of carpal tunnel release with ultrasound guidance (CTR-US) vs. mini-open carpal tunnel release (mOCTR) in patients with symptomatic carpal tunnel syndrome (CTS).

Eligible Conditions

  • Carpal Tunnel Syndrome
  • computerized tomography
  • Carpal Tunnel

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Carpal Tunnel Syndrome

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: 3 Month Follow-Up

3 Month Follow-Up
Device or Procedure related Adverse Events
EQ-5D-5L Change
Numeric Pain Scale Change
Return to normal daily activities within 3 days postoperatively
Time to Return to Work Among Employed Subjects
Time to return to normal daily activities (measured in days)

Trial Safety

Safety Progress

1 of 3

Other trials for Carpal Tunnel Syndrome

Trial Design

2 Treatment Groups

Mini Open Carpel Tunnel Release (mOCTR)
1 of 2
Carpal Tunnel Release with Ultrasound Guidance (CTR-US)
1 of 2
Active Control
Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: CTR-US · No Placebo Group · N/A

Carpal Tunnel Release with Ultrasound Guidance (CTR-US)
Experimental Group · 1 Intervention: CTR-US · Intervention Types: Device
Mini Open Carpel Tunnel Release (mOCTR)
ActiveComparator Group · 1 Intervention: mOCTR · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 month follow-up
Closest Location: Orthopedic Associates · Fort Walton Beach, FL
Photo of florida 1Photo of florida 2Photo of florida 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Carpal Tunnel Syndrome
0 CompletedClinical Trials

Who is running the clinical trial?

Sonex Health, Inc.Lead Sponsor
1 Previous Clinical Trials
411 Total Patients Enrolled
1 Trials studying Carpal Tunnel Syndrome
411 Patients Enrolled for Carpal Tunnel Syndrome
Kyle Eberlin, MDPrincipal InvestigatorMassachusetts General Hospital

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years old.
You have clinically significant CTS in the ipsilateral hand.
You have previously failed nonsurgical treatment options for your symptomatic shoulder.
You have a valid mobile phone number and email address to receive and answer follow-up questionnaires.
You agree to complete follow-up questionnaires over a 12-month period.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.